Article Information
- Received February 27, 2013
- Revision received July 10, 2013
- Accepted August 11, 2013
- First published September 11, 2013.
- Version of record published September 11, 2013.
Author Information
- Jianhua Xu1,
- Lynsie Morris1,
- Arjun Thapa1,
- Hongwei Ma1,
- Stylianos Michalakis2,
- Martin Biel2,
- Wolfgang Baehr3,
- Igor V. Peshenko4,
- Alexander M. Dizhoor4, and
- Xi-Qin Ding1
- 1Department of Cell Biology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104,
- 2Center for Integrated Protein Science Munich and Department of Pharmacy–Center for Drug Research, Ludwig-Maximilians-Universität München, 80539 Munich, Germany,
- 3John A. Moran Eye Center, University of Utah, Salt Lake City, Utah 84132, and
- 4Department of Basic Sciences and Pennsylvania College of Optometry, Salus University, Elkins Park, Pennsylvania 19027
Author contributions
Author contributions: J.X., S.M., M.B., W.B., A.M.D., and X.-Q.D. designed research; J.X., L.M., A.T., H.M., and I.V.P. performed research; J.X., L.M., A.T., H.M., and I.V.P. analyzed data; J.X., S.M., W.B., A.M.D., and X.-Q.D. wrote the paper.
Disclosures
- Received February 27, 2013.
- Revision received July 10, 2013.
- Accepted August 11, 2013.
This work was supported by grants from the National Center for Research Resources (P20RR017703), the National Eye Institute (P30EY12190, R01EY019490, R01EY08123, R01EY019298, and R01EY011522), the Oklahoma Center for the Advancement of Science & Technology, and the Deutsche Forschungsgemeinschaft. We thank Drs. Anand Swaroop, Jan De Vente, Cheryl Craft, Muna Naash, and Jonathan Lytton for providing Nrl−/− mouse line and antibodies for cGMP, M-opsin, CAR, S-opsin, and NCKX2.
The authors declare no competing financial interests.
- Correspondence should be addressed to Xi-Qin Ding, 940 Stanton L. Young Boulevard, BMSB 553, Oklahoma City, OK 73104. xi-qin-ding{at}ouhsc.edu
Online Impact